What is the half-life of trazodone?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Trazodone Half-Life

The elimination half-life of trazodone is approximately 7-9 hours in healthy adults, though this can extend to 10-12 hours depending on the study population. 1, 2

Pharmacokinetic Details

The half-life of trazodone has been consistently documented across multiple studies:

  • Terminal elimination half-life ranges from 7.3 to 8.6 hours in healthy human subjects after oral administration 2
  • One early pharmacokinetic study reported a biphasic elimination pattern with a redistribution half-life of approximately 1 hour and an elimination half-life of 10-12 hours 1
  • Another study described the biphasic elimination as 4.4 hours for the first 10 hours and 7.5 hours for the next 24 hours 3
  • After intravenous administration in horses (for comparative reference), the elimination half-life was 8.58 hours, with terminal phase half-life of 7.11 hours after oral administration 4

Clinical Implications for Dosing

Despite the relatively short half-life of 7-9 hours, trazodone's clinical duration of action for sedation is only 6-8 hours, which is why it requires multiple daily doses for continuous therapeutic effect. 5, 6

Key dosing considerations:

  • The 3- to 9-hour half-life favors dose-weighting at bedtime for patients using trazodone as an antidepressant 6
  • Single nighttime dosing (150 mg predominantly at bedtime, increased to 200-300 mg as needed) is equally effective as multiple daily dosing for depression treatment 6
  • For patients with PTSD-related nightmares, the mean effective dose was 212 mg/day, though the dosing frequency was not specified in the guideline 5

Absorption and Metabolism

  • Trazodone is nearly completely absorbed after oral administration 1
  • Food delays absorption and reduces peak serum concentration (from 1.88 to 1.47 mcg/mL) but does not alter total bioavailability (approximately 63-65%) 2
  • Less than 0.13% is excreted unchanged in urine, indicating extensive hepatic metabolism 2
  • The drug is metabolized hepatically by hydroxylation and oxidation to probably inactive metabolites 1

References

Research

Antidepressant properties of trazodone.

Clinical pharmacy, 1982

Research

Trazodone (Desyrel, Mead-Johnson Pharmaceutical Division).

Drug intelligence & clinical pharmacy, 1982

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Trazodone dosing regimen: experience with single daily administration.

The Journal of clinical psychiatry, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.